CIK 0001053369 · Non-accelerated filer<br>Smaller reporting company
ELITE PHARMACEUTICALS INC /NV/
Sign in to watch- Ticker
- ELTP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 223542636
- Phone
- 2017502646
- Business address
- 165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
- Former names
- ELITE PHARMACEUTICALS INC /DE/
- Open-market buys, last 90 days
- $34,590
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$34,590. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-06-17 | TREPPEL JERRY Chairman of the Board | Conversion · Warrants | −375,000 | $0.25 | $94K | 0 |
| 2014-05-09 | NARINE JEENARINE Director | Sale | −329,437 | $0.38 | $126K | 5,510,455 |
| 2014-04-23 | Dash Barry H Director | Conversion | +12,423 | $0.25 | $3K | 1,025,754 |
| 2014-04-23 | Dash Barry H Director | Conversion · Warrants | −12,423 | $0.25 | $3K | 0 |
| 2014-04-02 | NARINE JEENARINE Director | Sale | +147,667 | $0.41 | $61K | 5,682,877 |
| 2014-04-02 | NARINE JEENARINE Director | Sale | −147,664 | $0.41 | $61K | 5,839,892 |
| 2014-04-01 | NARINE JEENARINE Director | Sale | −157,012 | $0.41 | $65K | 5,830,544 |
| 2014-03-27 | NARINE JEENARINE Director | Sale | −190,172 | $0.43 | $81K | 5,987,556 |
| 2014-03-12 | TREPPEL JERRY Chairman of the Board | Option exercise | +180,000 | $0.06 | $11K | 2,831,558 |
| 2014-03-12 | TREPPEL JERRY Chairman of the Board | Option exercise · Options | −180,000 | 0 | ||
| 2014-03-11 | NARINE JEENARINE Director | Sale | −239,367 | $0.60 | $144K | 14,887,229 |
| 2014-03-11 | NIGALAYE ASHOK G Chief Scientific Officer | Sale | −239,367 | $0.60 | $144K | 20,300,770 |
| 2014-03-11 | EPIC PHARMA LLC 10% owner | Sale | −239,367 | $0.60 | $144K | 67,669,232 |
| 2014-03-11 | EPIC INVESTMENTS, LLC 10% owner | Sale | −239,367 | $0.60 | $144K | 67,669,232 |
| 2014-03-07 | NARINE JEENARINE Director | Sale | −1,051,450 | $0.68 | $715K | 14,939,890 |
| 2014-03-07 | NIGALAYE ASHOK G Chief Scientific Officer | Sale | −1,051,450 | $0.68 | $715K | 20,372,580 |
| 2014-03-07 | EPIC PHARMA LLC 10% owner | Sale | −1,051,450 | $0.68 | $715K | 67,908,599 |
| 2014-03-07 | EPIC INVESTMENTS, LLC 10% owner | Sale | −1,051,450 | $0.68 | $715K | 67,908,599 |
| 2014-03-06 | NARINE JEENARINE Director | Sale | −773,050 | $0.90 | $692K | 15,171,209 |
| 2014-03-06 | NIGALAYE ASHOK G Chief Scientific Officer | Sale | −773,050 | $0.90 | $692K | 20,688,015 |
Page 9 of 18 · 356 trades